National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 367212

Government Disclaimer on use of this data

Case Details

VAERS ID: 367212 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:165
Submitted: 2009-11-13
   Days after onset:241
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Acute myeloid leukaemia
SMQs:, Haematological malignant tumours (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC Split Type: B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166